Seminars in Oncology
Volume 35, Issue 1 , Pages 17-24 , February 2008

Inflammatory Breast Cancer in Tunisia: Reassessment of Incidence and Clinicopathological Features

References 

  1. El Saghir NS, Khalil MK, Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg. 2007;5:225–233
  2. Ben Ahmed S, Aloulou S, Bibi M, Landolsi A, Nouira M, Ben Fatma L, et al. Breast cancer prognosis in Tunisian women: analysis of a hospital series of 729 patients. Sante Publique. 2002;14:231–241
  3. Maalej M, Hentati D, Mesai T, et al. Breast cancer in Tunisia. National prospective study in the year 2004. Bull Cancer. In press.
  4. National Institute of Health Database. Algiers, Algeria: Ministry of Health; 2002;
  5. Mourali N, Muenz L, Tabbane F, et al. Epidemiologic features of rapidly progressing breast cancer in Tunisia. Cancer. 1980;46:2741–2746
  6. Mourali N, Tabbane F, Muenz LR, et al. Preliminary results of primary systemic chemotherapy in association with surgery or radiotherapy in rapidly progressing breast cancer. Br J Cancer. 1982;45:367–374
  7. Cancer Registry of the North of Tunisia. Tunis, Tunisia: Ministry of Health; 1997;
  8. Maalej M, Frikha H, Ben Salem S, et al. Breast cancer in Tunisia: clinical and epidemiological study. Bull Cancer. 1999;86:302–306
  9. Hance KH, Anderson WF, Devesa SS, Young HA, Levine PH. Trends in inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology and End Results Program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966–975
  10. Chang S, Parker SL, Pham T, et al. Inflammatory breast cancer incidence and survival: the Surveillance, Epidemiology and End Results program of the National Cancer Institute, 1975-1992. Cancer. 1998;82:2366–2372
  11. Levine PH, Steinhorn SC, Ries LG, Aron JL. Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) program. J Natl Cancer Inst. 1985;74:291–297
  12. Charafe-Jauffret E, Mrad K, Labidi IS, et al. Inflammatory breast cancers in Tunisia and France show similar immunophenotypes. Breast. 2007;16:352–358
  13. Anderson WF, Chu KC, Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?. J Clin Oncol. 2003;21:2254–2259
  14. Smoot RL, Koch CA, Degnim AC, et al. A single-center experience with inflammatory breast cancer, 1985-2003. Arch Surg. 2006;141:567–572
  15. Gunhan-Bilgen I, Ustun EE, Memis A. Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology. 2002;223:829–838
  16. Le MG, Arriagada R, Contesso G, et al. Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients. Clin Breast Cancer. 2005;6:439–445
  17. Haagensen CD. Inflammatory carcinoma (Disease of the breast). In: Philadelphia, PA: Saunders; 1971;p. 576–584
  18. Denoix P. Treatment of malignant tumors of the breast. Recent Results Cancer Res. 1970;31:6–10
  19. Bonnier P, Charpin C, Lejeune C, et al. Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?. Int J Cancer. 1995;62:382–385
  20. Cristofanilli M, Buzdar AU, Hortobagyi GN. Update on the management of inflammatory breast cancer. Oncologist. 2003;8:141–148
  21. Aziz SA, Pervez S, Kham S, et al. Case-control study of prognostic markers and disease outcome in inflammatory breast carcinoma: a unique clinical experience. Breast J. 2001;7:398–404
  22. Cristofanilli M, Valero V, Buzdar AU, et al. Inflammatory breast cancer and patterns of recurrence: understanding the biology of a unique disease. Cancer. 2007;110:1436–1444
  23. Gonzalez-Angulo AM, Hennessy BT, Broglio K, et al. Trends for inflammatory breast cancer: is survival improving?. Oncologist. 2007;12:904–912

PII: S0093-7754(07)00242-4

doi: 10.1053/j.seminoncol.2007.11.017

Seminars in Oncology
Volume 35, Issue 1 , Pages 17-24 , February 2008